Hocoma has close cooperations with different partners.
The fundamental development steps in the Lokomat system took place in the Rehabilitation and Research Centre of Balgrist University Hospital specialized in spinal cord injury. The further development of the Lokomat system is being attended together with clinical research at Balgrist University Hospital. In this way, there is a guarantee that the requirements and experience of the customers - i.e. the patients, therapists and hospitals - are included in the development.
The CABRR is part of the Medstar National Rehabilitation Hospital and the Catholic University of America, Washington, D.C. It is focused on the application of engineering methods to advance the treatment of movement disorders following neurologic injury.
Dr. Peter Lum directs CABRR, and along with Dr. Elizabeth Brokaw, performed development and clinical testing of the HandSOME device for assisting grasping movements in individuals with impaired hand function. Hocoma worked with the CABRR to transfer this technology, resulting in the ManovoSpring.
ETH Zurich is a technical and scientific university with excellent international research reputation. ETH Zurich is place of study, research and work for over 20,000 people from 80 different nations. About 370 professorships in 16 departments are responsible for high-quality research and teaching in the fields of technical, mathematical and natural sciences.
Hocoma cooperates with the Sensory-Motor Systems Lab (SMS Lab) of the Institute of Robotics and Intelligent Systems (IRIS) in developing innovative technological solutions for rehabilitation. The SMS Lab is the scientific partner for research of patient-cooperative control strategies which are mainly used for Lokomat and ArmeoPower. In addition SMS Lab supports Hocoma in the advancement and clinical evaluation of robotic therapy solutions.
The ETH Zurich is widely recognized as the leading technical university in continental Europe, with a strong track record of pioneering research in engineering and biomedical sciences. ETH Zurich is place of study, research and work for approximately 20,000 people from 80 different nations. About 500 professorships in 16 departments are responsible for high-quality research and teaching in the fields of technical, mathematical and natural sciences.
In the ArmeoSenso project, funded by the Swiss government Commission for Technology and Innovation (CTI), Hocoma has collaborated with the Rehabilitation Engineering Lab (ReLab) of ETH Professor Roger Gassert, to develop and clinically evaluate a prototype of a sensor-based arm rehabilitation system for stroke patients using low-cost inertial measurement units (IMUs). The lessons learned during this project are now being deployed to develop a future generation of Armeo products.
The Spinal Cord Injury Center at the Heidelberg University Hospital represents an internationally recognized institution for the in-patient and out-patient treatment of individuals suffering from spinal cord injury. Besides providing comprehensive care to traumatic as well as non-traumatic spinal cord injury patients, we have a strong focus in investigating novel therapeutic approaches to improve their quality of life and independence beyond the current state of the art.
A close cooperation with Hocoma exists since the company has been founded. The Heidelberg University Hospital has participated in the first clinical trial showing the efficacy of the Lokomat and contributed to the development of the Erigo and its clinical evaluation.
idiag offers colleges, universities and other research centers a platform where long unrealized product potential is recognized and developed into commercial maturity. The mission of the company is to transform innovative ideas into market-ready products. To accomplish this, idiag networks the specialist areas of science with development and production as well as marketing and sales.
The spinal measurement device of idiag is part of Hocoma’s innovative idea for low back pain therapy, the Valedo Therapy Concept. The ValedoShape is an easy to use measuring device for computer assisted representation of the spine.
The mission of the Biorobotics Laboratory at U.C. Irvine is to develop robotic and mechatronic devices that transform human movement, motor learning, and rehabilitation. One focus is the development of cost-efficient devices that patients can use to exercise and optimize recovery on their own, based on a scientific understanding of neuromotor plasticity and motor learning. Directed by Prof. David Reinkensmeyer, the Biorobotics Laboratory developed the first prototype of the ArmeoSpring in close collaboration with the Rehabilitation Institute of Chicago (RIC) and Tariq Rahman of the Alfred I. duPont Hospital for Children. Hocoma worked with U.C. Irvine to transfer the technology, resulting in the successful launch of the ArmeoSpring therapy system in 2007. Hocoma, U.C. Irvine, and RIC continue to collaborate to further enhance the ArmeoSpring therapy system.
Johns Hopkins Hospital is widely considered one of the best medical centers of excellence in the world. Hocoma collaborates with the research team of Prof. John Krakauer, a world renowned neurologist and neuroscientist, in developing next-generation games that motivate patients to bring their therapy intensity to the next level. Prof. Krakauer also leads the world's first large multi-center trial of robotics in early sub-acute stroke patients, sponsored by the National Institutes of Health, which chose to use the ArmeoPower.
The Rehabilitation Institute of Chicago (RIC) is the nation’s #1 ranked provider of comprehensive physical medicine and rehabilitation care to patients from around the world and is the leader in research and development of the cutting-edge treatments and technologies in its field. Through repair, regeneration and recovery of the brain, spinal cord and musculoskeletal system, RIC advances the ability of its patients to help them to achieve their goals and pursue their life’s passions.
RIC holds an unparalleled market distinction with a record six federal research designations awarded and funded by the National Institutes of Health (NIH) and the Department of Education’s National Institute of Disability and Rehabilitation Research (NIDRR) in the areas of spinal cord injury, traumatic brain injury, stroke, neurological rehabilitation, outcomes research and rehabilitation engineering research. In fact, the ArmeoSpring has been developed together with researchers and physicians from RIC.
Robert Bosch Hospital is a teaching hospital of the University of Tübingen. Hocoma collaborates with Prof. Clemens Becker, Chief Medical Officer for geriatric rehabilitation and leading international expert on fall prevention. A joint multi-center trial with BGU Hospitals, one of the largest trauma treatment center chains in Germany, is currently investigating the use of ArmeoSpring to help orthopedic patients regain arm function after shoulder fractures caused by elderly falls.
Biomechanical Engineering is a research group of MIRA, the Institute for Biomedical Technology and Technical Medicine of the University of Twente. With its science, MIRA sets standards in the field of new technology for healthcare. Moreover, it brings those new technologies to the market, effectively stimulating change, renewal and progress in clinical applications. MIRA is the only scientific organization in Europe that holds fundamental, applied and clinical chairs.
The ArmeoBoom was developed based on a research prototype developed by scientists of MIRA and in close collaboration with therapists, clinicians and researchers from the Roessingh Research and Development. The aim of the development was to provide a lightweight and movable therapy platform for patients with mild to moderate upper extremity impairments, allowing free movements in a large workspace supported by an arm weight support system with little inertia. In close collaboration between the involved centres, the ArmeoBoom will be clinically tested in a Dutch national multicentre trial.
Xsens is the leading innovator in 3D motion tracking technology and products. Its sensor fusion technologies enable a seamless interaction between the physical and the digital world in consumer electronics devices and professional applications such as 3D character animation, motion analysis, and industrial control & stabilization. Hocoma worked closely with Xsens to get access to proven, low power, high performance 3D motion tracking technology and system design and to take Valedo to the mass market.
The School of Health Professions at the Zurich University of Applied Sciences is one of the largest and most renowned centres for basic and continuing education in diverse health professions, such as occupational therapy, nursing and physiotherapy, as well as for research and development in those fields.
Its projects focus on patients with pain and functional disorders of their locomotor system. The results of these projects are used to develop a more evidence-based physiotherapy. The basic development of the Valedo has been achieved in cooperation with the research department of physiotherapy of the Zurich University of Applied Sciences.